E11.3551 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

Name of the Condition

• Common Name: Type 2 Diabetes with Stable Proliferative Diabetic Retinopathy, Right Eye
• Medical Term: Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina of the right eye, with no active progression or worsening of retinal changes. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The "stable" designation indicates that the proliferative changes are not actively advancing, though ongoing monitoring is essential.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure. In the stable phase, the abnormal vessels are present but not actively proliferating or causing new complications.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Often asymptomatic in early stages.
• Blurred or distorted vision in the right eye.
• Floaters or dark spots in the visual field of the right eye.
• Sudden vision loss in severe cases (rare in stable phase).

Diagnosis

Diagnosis requires a comprehensive dilated eye exam by an ophthalmologist, often supplemented by fundus photography, fluorescein angiography, or optical coherence tomography. The "stable" designation is confirmed by the absence of active neovascularization, hemorrhage, or retinal detachment.

Treatment Options

• Laser photocoagulation to reduce abnormal blood vessel growth.
• Intravitreal anti-VEGF injections to inhibit vascular proliferation.
• Regular monitoring to detect progression.
• Blood sugar and blood pressure control to slow disease advancement.

Prognosis and Follow-Up

With proper management, vision loss can be prevented or minimized. Follow-up typically includes regular eye exams every 3–6 months to monitor for changes. Stable proliferative retinopathy may remain unchanged for years with good glycemic control, but progression to unstable or advanced stages is possible without consistent care.

Complications

• Vision loss or blindness if untreated.
• Retinal detachment.
• Vitreous hemorrhage.
• Macular edema (if stability is lost).

Lifestyle & Prevention

• Maintain tight blood glucose control.
• Manage blood pressure and cholesterol.
• Avoid smoking.
• Regular eye screenings for early detection.
• Adopt a healthy diet and exercise routine.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, floaters, or pain in the right eye, as these may indicate progression to unstable proliferative retinopathy or other complications.

Tips for Medical Coders

Document the laterality (right eye) and the "stable" designation clearly in the medical record. Ensure the diagnosis is supported by clinical findings, such as a dilated eye exam or imaging, to confirm the absence of active progression. The code E11.3551 specifically requires documentation of the right eye and stable proliferative changes.